Related references
Note: Only part of the references are listed.Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Metformin and cardiorenal outcomes in diabetes: A reappraisal
John R. Petrie et al.
DIABETES OBESITY & METABOLISM (2020)
Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung et al.
EBIOMEDICINE (2020)
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study
Yongze Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome
Haoran Wu et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
International traditional Chinese medicine guideline for diagnostic and treatment principles of diabetes
Fengmei Lian et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Standards of medical care for type 2 diabetes in China 2019
Weiping Jia et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Serena Sanna et al.
NATURE GENETICS (2019)
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical Trial
Xiaotong Yu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial
Xiaolin Tong et al.
MBIO (2018)
Reduction in hepatic secondary bile acids caused by short-term antibiotic-induced dysbiosis decreases mouse serum glucose and triglyceride levels
Takuya Kuno et al.
SCIENTIFIC REPORTS (2018)
The prevalence, awareness, treatment and control of dyslipidemia among adults in China
Ling Pan et al.
ATHEROSCLEROSIS (2016)
Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China
Li Yan et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
Tao Xu et al.
DIABETES CARE (2015)
Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula
Jia Xu et al.
ISME JOURNAL (2015)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
An-Wen Chan et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes A report from the Swedish National Diabetes Register
Bjorn Eliasson et al.
DIABETES CARE (2011)
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis
HC Gerstein et al.
DIABETOLOGIA (2005)
Share Paper
